Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093711410> ?p ?o ?g. }
- W3093711410 endingPage "102989" @default.
- W3093711410 startingPage "102989" @default.
- W3093711410 abstract "The majority of new HCV infections in Canada occur in people who inject drugs. Thus, while curative direct antiviral agents (DAAs) herald a promising new era in hepatitis C virus (HCV) treatment, improving the lives and wellbeing of people living with HCV (PLHCV) must be considered in the context of reducing overdose-related harms and with a syndemic lens. We measure drug-related deaths (DRDs) among HCV-negative people and PLHCV in British Columbia (BC), Canada, and the impact of potent contaminants like fentanyl on deaths. We identified DRDs among PLHCV and HCV-negative individuals from 2010 to 2018 in the BC Hepatitis Testers Cohort, a population-based dataset of ~1.7 million British Columbians comprising comprehensive administrative and clinical data. We estimated annual standardized liver- and drug-related mortality rates per 100,000 person-years (PY) and described the contribution of specific drugs, including fentanyl and its analogues, implicated in DRDs over time. DRDs constituted 20.1% of deaths among PLHCV and 4.7% of deaths among HCV-negative individuals; a 4.3-fold (95% confidence interval: 4.0-4.5) difference. Drug-related mortality overtook liver-related mortality for PLHCV in 2015 and HCV-negative individuals in 2016 and rose from 241.7 to 436.5 per 100,000 PY from 2010 to 2018 amongPLHCV and from 20.0 to 57.1 per 100,000 PY for HCV-negative individuals over the same period. The proportion of deaths attributable to drugs among PLHCV and HCV-negative individuals increased from 15.1% to 26.1% and 3.1% to 8.0%, in 2010 and 2018, respectively. The proportion of DRDs attributed solely to synthetic opioids such as fentanyl averaged across both groups increased from 2.1% in 2010 to 69.6% in 2017. Steep drug-related mortality increases among PLHCV and HCV-negative individuals over the last decade highlight the urgent need to address overdose-related drivers and harms in these populations using an integrated care approach." @default.
- W3093711410 created "2020-10-29" @default.
- W3093711410 creator A5000896624 @default.
- W3093711410 creator A5005241464 @default.
- W3093711410 creator A5013553497 @default.
- W3093711410 creator A5015072695 @default.
- W3093711410 creator A5023403836 @default.
- W3093711410 creator A5029311932 @default.
- W3093711410 creator A5032853894 @default.
- W3093711410 creator A5037866883 @default.
- W3093711410 creator A5056044026 @default.
- W3093711410 creator A5067152843 @default.
- W3093711410 creator A5067233757 @default.
- W3093711410 creator A5071149176 @default.
- W3093711410 creator A5072619089 @default.
- W3093711410 creator A5074077824 @default.
- W3093711410 creator A5079171066 @default.
- W3093711410 creator A5085167909 @default.
- W3093711410 date "2020-12-01" @default.
- W3093711410 modified "2023-09-27" @default.
- W3093711410 title "Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada" @default.
- W3093711410 cites W2086064157 @default.
- W3093711410 cites W2178523807 @default.
- W3093711410 cites W2294032921 @default.
- W3093711410 cites W2412895207 @default.
- W3093711410 cites W2494835558 @default.
- W3093711410 cites W2506677318 @default.
- W3093711410 cites W2762642917 @default.
- W3093711410 cites W2776828305 @default.
- W3093711410 cites W2778170606 @default.
- W3093711410 cites W2788291693 @default.
- W3093711410 cites W2800878103 @default.
- W3093711410 cites W2808625126 @default.
- W3093711410 cites W2889982184 @default.
- W3093711410 cites W2890298149 @default.
- W3093711410 cites W2899887877 @default.
- W3093711410 cites W2908029346 @default.
- W3093711410 cites W2912770756 @default.
- W3093711410 cites W2938341655 @default.
- W3093711410 cites W2938543671 @default.
- W3093711410 cites W2940746649 @default.
- W3093711410 cites W2948067523 @default.
- W3093711410 cites W2951738555 @default.
- W3093711410 cites W2972879908 @default.
- W3093711410 cites W2980963477 @default.
- W3093711410 cites W2987866502 @default.
- W3093711410 cites W2988297670 @default.
- W3093711410 cites W3000019135 @default.
- W3093711410 cites W3023934849 @default.
- W3093711410 doi "https://doi.org/10.1016/j.drugpo.2020.102989" @default.
- W3093711410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7569420" @default.
- W3093711410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33091735" @default.
- W3093711410 hasPublicationYear "2020" @default.
- W3093711410 type Work @default.
- W3093711410 sameAs 3093711410 @default.
- W3093711410 citedByCount "7" @default.
- W3093711410 countsByYear W30937114102021 @default.
- W3093711410 countsByYear W30937114102022 @default.
- W3093711410 countsByYear W30937114102023 @default.
- W3093711410 crossrefType "journal-article" @default.
- W3093711410 hasAuthorship W3093711410A5000896624 @default.
- W3093711410 hasAuthorship W3093711410A5005241464 @default.
- W3093711410 hasAuthorship W3093711410A5013553497 @default.
- W3093711410 hasAuthorship W3093711410A5015072695 @default.
- W3093711410 hasAuthorship W3093711410A5023403836 @default.
- W3093711410 hasAuthorship W3093711410A5029311932 @default.
- W3093711410 hasAuthorship W3093711410A5032853894 @default.
- W3093711410 hasAuthorship W3093711410A5037866883 @default.
- W3093711410 hasAuthorship W3093711410A5056044026 @default.
- W3093711410 hasAuthorship W3093711410A5067152843 @default.
- W3093711410 hasAuthorship W3093711410A5067233757 @default.
- W3093711410 hasAuthorship W3093711410A5071149176 @default.
- W3093711410 hasAuthorship W3093711410A5072619089 @default.
- W3093711410 hasAuthorship W3093711410A5074077824 @default.
- W3093711410 hasAuthorship W3093711410A5079171066 @default.
- W3093711410 hasAuthorship W3093711410A5085167909 @default.
- W3093711410 hasBestOaLocation W30937114101 @default.
- W3093711410 hasConcept C126322002 @default.
- W3093711410 hasConcept C144024400 @default.
- W3093711410 hasConcept C149923435 @default.
- W3093711410 hasConcept C151730666 @default.
- W3093711410 hasConcept C159047783 @default.
- W3093711410 hasConcept C201903717 @default.
- W3093711410 hasConcept C2522874641 @default.
- W3093711410 hasConcept C2776408679 @default.
- W3093711410 hasConcept C2776455275 @default.
- W3093711410 hasConcept C2779343474 @default.
- W3093711410 hasConcept C2908647359 @default.
- W3093711410 hasConcept C71924100 @default.
- W3093711410 hasConcept C72563966 @default.
- W3093711410 hasConcept C86803240 @default.
- W3093711410 hasConcept C99454951 @default.
- W3093711410 hasConceptScore W3093711410C126322002 @default.
- W3093711410 hasConceptScore W3093711410C144024400 @default.
- W3093711410 hasConceptScore W3093711410C149923435 @default.
- W3093711410 hasConceptScore W3093711410C151730666 @default.
- W3093711410 hasConceptScore W3093711410C159047783 @default.
- W3093711410 hasConceptScore W3093711410C201903717 @default.